We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Laparoendoscopic Single-site Radical Nephrectomy for Localized Renal Cell Carcinoma (LESS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00945984
Recruitment Status : Unknown
Verified July 2009 by Seoul National University Hospital.
Recruitment status was:  Active, not recruiting
First Posted : July 24, 2009
Last Update Posted : July 28, 2009
Sponsor:
Information provided by:

Study Description
Brief Summary:
Surgical resection is the only potential curative treatment available for renal cell carcinoma. The purpose of this study is to clarify the surgical and oncologic outcomes of laparoendoscopic single-site radical nephrectomy for localized Renal Cell Carcinoma.

Condition or disease Intervention/treatment
Localized Renal Cell Carcinoma Procedure: Radical nephrectomy

Study Design

Study Type : Observational
Actual Enrollment : 36 participants
Observational Model: Case Control
Time Perspective: Retrospective
Official Title: Comparison of Laparoendoscopic Single-site Radical Nephrectomy With Conventional Laparoscopic Radical Nephrectomy for Localized Renal Cell Carcinoma
Study Start Date : March 2009

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts

Group/Cohort Intervention/treatment
LESS
Patients who underwent LESS radical nephrectomy
Procedure: Radical nephrectomy
Surgical options to treat localized renal cell carcinoma
Conventional laparoscopy
Patients who underwent conventional laparoscopic radical nephrectomy
Procedure: Radical nephrectomy
Surgical options to treat localized renal cell carcinoma


Outcome Measures

Primary Outcome Measures :
  1. Surgical outcomes such as operative time, estimated blood loss [ Time Frame: 1 year ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Tertiary care center
Criteria

Inclusion Criteria:

  • Patients with localized renal cell carcinoma

Exclusion Criteria:

  • Patients with lymph node or distant metastasis
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00945984


Locations
Korea, Republic of
Seoul National University Hospital
Seoul, Korea, Republic of, 110-744
Sponsors and Collaborators
Seoul National University Hospital
Investigators
Study Chair: Hyeon Hoe Kim, PhD Seoul National University Hospital
More Information

Responsible Party: Hyeon Hoe Kim, Seoul National University Hospital
ClinicalTrials.gov Identifier: NCT00945984     History of Changes
Other Study ID Numbers: LESSRNx
First Posted: July 24, 2009    Key Record Dates
Last Update Posted: July 28, 2009
Last Verified: July 2009

Keywords provided by Seoul National University Hospital:
Localized renal cell carcinoma

Additional relevant MeSH terms:
Carcinoma
Carcinoma, Renal Cell
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms
Adenocarcinoma
Kidney Neoplasms
Urologic Neoplasms
Urogenital Neoplasms
Neoplasms by Site
Kidney Diseases
Urologic Diseases